Galena Biopharma to Present at the 2012 Biotechnology Industry Organization (BIO) International Convention

LAKE OSWEGO, Ore., June 18, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2012 BIO International Convention. The presentation will take place on Wednesday, June 20, 2012 at 9:30 a.m. EDT at the Boston Convention and Exhibition Center in Boston, MA.